During the last session, Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares were 0.4 million, with the beta value of the company hitting -1.63. At the end of the trading day, the stock’s price was $3.54, reflecting an intraday gain of 1.72% or $0.06. The 52-week high for the TPST share is $9.77, that puts it down -175.99 from that peak though still a striking 95.2% gain since the share price plummeted to a 52-week low of $0.17. The company’s market capitalization is $78.66M, and the average trade volume was 979.61K shares over the past three months.
Tempest Therapeutics Inc (NASDAQ:TPST) trade information
Tempest Therapeutics Inc (TPST) registered a 1.72% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.72% in intraday trading to $3.54, hitting a weekly high. The stock’s 5-day price performance is 14.19%, and it has moved by -4.58% in 30 days. Based on these gigs, the overall price performance for the year is 96.67%.
Tempest Therapeutics Inc (TPST) estimates and forecasts
Statistics show that Tempest Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Tempest Therapeutics Inc (TPST) shares have gone down -22.20% during the last six months, with a year-to-date growth rate more than the industry average at 17.28% against 10.40.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 62.66%. While earnings are projected to return 20.37% in 2024.
TPST Dividends
Tempest Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
